COMMUNIQUÉS West-GlobeNewswire

Biocartis Group NV: Biocartis announces CE-IVD marking of its Idylla(TM) MSI Test
28/02/2019
PRESS RELEASE 28 February 2019, 07:01 CET Biocartis announces CE-IVD marking of its Idylla(TM) MSI Test Mechelen, Belgium, 28 February 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2018
28/02/2019
Financial Statements Release January 1-December 31, 2018 Progress from safety studies toward clinical proof-of-concept Highlights in January-December 2018: Herantis Pharma ("Herantis") completed the patient enrolment in [...]
Financière de Tubize SA : Annual Financial Report 2018
28/02/2019
Press release 28 February 2019 - 8:00h CET FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, directeur, aspijcke@icloud.com Annual financial report 2018 Regulated [...]
Financière de Tubize SA : Rapport financier annuel 2018
28/02/2019
Communiqué de presse 28 février 2019 - 8:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, directeur, aspijcke@icloud.com Rapport financier annuel 2018 Information [...]
Oxurion NV to Present Preclinical Evaluation of Plasma Kallikrein Inhibition for DME at 2019 EURETINA Winter Meeting
28/02/2019
Leuven, Belgium, 28 February 2019 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetic eye disease, announces today that it [...]
Verona Pharma to Present at Cowen and Company 39th Annual Health Care Conference
28/02/2019
LONDON, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
EUROBIO SCIENTIFIC : SUCCES D'UNE AUGMENTATION DE CAPITAL PAR PLACEMENT PRIVE DE 3 MILLIONS D’EUROS
28/02/2019
EUROBIO SCIENTIFIC ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL PAR VOIE DE PLACEMENT PRIVE POUR UN MONTANT DE 3 MILLIONS D’EUROS Emission de 1 million d’actions ordinaires nouvelles avec suppression du droit [...]
Terveystalo Plc: Report by the Board of Directors, Financial Statements and Corporate Governance Statement 2018 published
28/02/2019
Terveystalo Plc Annual Financial Report 28 February at 9:00 am EET Terveystalo has published its Annual Report 2018 at https://www.terveystalo.com/en/annual-review-2018/ . The Annual Report 2018 includes the Report by [...]
Genmab A/S Summons Annual General Meeting
28/02/2019
Company Announcement Genmab A/S to hold Annual General Meeting on March 29, 2019 Copenhagen, Denmark; Thursday, February 28, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) summons the Annual General Meeting on Friday, March [...]
MDxHealth (R): MDxHealth Reports Financial Year 2018 Results and Provides Outlook for 2019
28/02/2019
NEWS RELEASE REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, February 28, 2019 - MDxHealth SA (Euronext: MDXH.BR), today announced its business update and financial results for the year ended [...]
MDxHealth (R) : MDxHealth communique ses résultats financiers pour l'exercice 2018 et ses perspectives pour 2019
28/02/2019
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST, jeudi 28 février 2019 - MDxHealth SA (Euronext : MDXH.BR) publie aujourd'hui son rapport d'activité et ses résultats [...]
Biocartis Group NV: BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK
28/02/2019
PRESS RELEASE: REGULATED INFORMATION Thursday, 28 February 2019, 07:00 CET BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK Mechelen, Belgium , 28 February 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an [...]
OSE Immunotherapeutics to Present New Clinical and Preclinical Data on its Immuno-Oncology Portfolio at AACR 2019
28/02/2019
Oral presentation will highlight early signs of activity of Tedopi® from the ongoing Phase 3 trial in Non-Small Cell Lung Cancer NANTES, France, Feb. 28, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: [...]
Pixium Vision to host KOL Meeting on March 5, 2019 in Paris
28/02/2019
Paris, France. February 28, 2019 – 7.00 AM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more [...]
Pixium Vision organise un KOL Meeting le 5 Mars 2019 à Paris
28/02/2019
Paris, 28 février 2019 – 7h00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon [...]
Abattis Provides Update on Conference Call
28/02/2019
VANCOUVER, British Columbia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) provides the following update on the Company’s recent trading halt and [...]
Alder BioPharmaceuticals, Inc. Prices Public Offering of Common Stock
28/02/2019
BOTHELL, Wash., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]
Kaleido Biosciences Announces Pricing of Initial Public Offering
28/02/2019
LEXINGTON, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]
Neon Therapeutics to Present at the American Association for Cancer Research Annual Meeting
28/02/2019
CAMBRIDGE, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced upcoming presentations at [...]

Pages